SCHEMBL1015802

SCHEMBL1015802

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)NCc1cccc(-c2ccoc2)c1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.84
L3MBTL1 Q9Y468 2/20 0.41
PLA2G1B P04054 1/20 0.41
HTT P42858 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
CNR1 P21554 1/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ANO1 Q5XXA6 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.39
ALDH1A1 P00352 4/20 0.39
POLB P06746 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPK10 P53779 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MAPK1 P28482 1/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
G6PD P11413 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1014985 0.91 SERPINE1 (1.00) SERPINE1L3MBTL1PLA2G1BHTTATG4B
SCHEMBL1015662 0.87 SERPINE1 (0.64) SERPINE1HTTCNR1MAPTKDM4E
SCHEMBL1016838 0.87 SERPINE1 (0.81) SERPINE1CNR1MAPTKDM4EADAMTS5
SCHEMBL418556 0.86 SERPINE1 (0.61) SERPINE1CNR1KDM4EALDH1A1POLB
SCHEMBL1015337 0.86 SERPINE1 (0.62) SERPINE1L3MBTL1PLA2G1BHTTATG4B
SCHEMBL419000 0.84 SERPINE1 (0.60) SERPINE1L3MBTL1CNR1KDM4EALDH1A1
SCHEMBL1015659 0.84 SERPINE1 (0.60) SERPINE1L3MBTL1PLA2G1BHTTATG4B
SCHEMBL1015109 0.83 SERPINE1 (0.57) SERPINE1KDM4EALDH1A1MEN1KMT2A
SCHEMBL1015614 0.83 SERPINE1 (0.57) SERPINE1HTTMAPTKDM4EALDH1A1
SCHEMBL419148 0.83 SERPINE1 (0.82) SERPINE1L3MBTL1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885L3MBTL1 2670/4885PLA2G1B 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.